pyridinoline has been researched along with gestodene in 3 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 3 (100.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Ajossa, S; Floris, S; Guerriero, S; Mannias, M; Melis, GB; Orrù, M; Paoletti, AM; Vacca, AM | 1 |
| Acunzo, G; Bifulco, G; Di Carlo, C; Di Spiezio Sardo, A; Guida, M; Nappi, C; Tommaselli, GA | 1 |
| Di Spiezio Sardo, A; Giordano, E; Greco, E; Guida, M; Nappi, C; Tommaselli, GA | 1 |
3 trial(s) available for pyridinoline and gestodene
| Article | Year |
|---|---|
Evidence that treatment with monophasic oral contraceptive formulations containing ethinylestradiol plus gestodene reduces bone resorption in young women.
Topics: Adult; Amino Acids; Bone Resorption; Contraceptives, Oral; Ethinyl Estradiol; Female; Humans; Norpregnenes; Osteocalcin; Sex Hormone-Binding Globulin | 2000 |
Effects of a low-dose and ultra-low-dose combined oral contraceptive use on bone turnover and bone mineral density in young fertile women: a prospective controlled randomized study.
Topics: Absorptiometry, Photon; Adult; Amino Acids; Bone Density; Bone Resorption; Contraceptives, Oral, Combined; Drug Administration Schedule; Ethinyl Estradiol; Female; Humans; Norpregnenes; Osteocalcin; Prospective Studies; Treatment Outcome | 2003 |
Effects of an oral contraceptive containing drospirenone on bone turnover and bone mineral density.
Topics: Adult; Amino Acids; Androstenes; Bone Density; Bone Remodeling; Calcium; Contraceptives, Oral, Combined; Contraceptives, Oral, Synthetic; Ethinyl Estradiol; Female; Humans; Norpregnenes; Osteocalcin; Progesterone Congeners | 2005 |